According to statements from both organizations, the transaction, mainly a capital increase in exchange for a minority stake, is now complete, marking the largest healthcare investment of its kind in the Egyptian market to date.

Since the agreement was first signed in July 2025, Alameda has continued to pursue its growth objectives, including expanding its presence into sub-Saharan Africa with a new clinic in Kenya.

The group has also recorded an increase in international patients from across the region travelling to its facilities for specialised treatment.

Under the terms of the deal, DPI will work closely with Alameda’s existing leadership team to support the healthcare provider’s expansion plans.

Dr. Fahad Khater, the group’s chairman, remains the majority shareholder and will continue to lead the company’s strategic direction.

DPI partner Ziad Abaza said the firm is pleased to have concluded a major milestone transaction and looks forward to partnering with Alameda’s management to enhance access to high-quality care not only in Egypt but also in the Gulf Cooperation Council (GCC) region.

The financing is expected to accelerate Alameda’s efforts to broaden its footprint, invest in modern medical technologies and strengthen specialised centres of excellence across its network.

The broader initiative aligns with trends in the region toward improving healthcare infrastructure and positioning Egypt as a destination for medical value travel and advanced clinical services.